BREAKING NEWS Mission Fire burns structure in Tehama County Full Story
BREAKING NEWS Five new Covid-19 cases reported in Shasta County Saturday Full Story

FDA announces recall of another heart medicine for possible cancer risk

The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high bl...

Posted: Oct 31, 2018 6:46 PM
Updated: Oct 31, 2018 6:46 PM

The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time, SciGen is recalling certain lots of irbesartan.

The recalled lot will have "Westminster Pharmaceuticals" and "GSMS Inc." on the label, according to the FDA list.

Business and industry sectors

Business, economy and trade

Cancer

Company activities and management

Consumer protection

Diseases and disorders

Government organizations - US

Health and medical

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Product management

Product recalls

Society

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Continents and regions

North America

The Americas

United States

Another heart medicine, valsartan, has also been recalled recently due to contamination.

Irbesartan is an angiotensin II receptor blocker, or ARB. This is a drug that blocks a potent chemical in the blood called anigiotensin, which causes muscles surrounding blood vessels to contract from binding with angiotensin II receptors. When the chemical binds, it narrows the vessels, and that can cause high blood pressure.

FDA tests showed that the recalled lots of these drugs contained N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a lubricant additive, according to the National Institutes of Health.

This is the first non-valsartan drug product that the agency has found to contain the NDEA impurity.

Several pills that contain valsartan have been under a recall since July. The drugs were tainted with NDEA or NDMA, N-nitrosodimethylamine, an impurity that is also considered a possible carcinogen by the US Environmental Protection Agency.

NDMA is an organic chemical used to make liquid rocket fuel and a byproduct of manufacturing some pesticides and processing fish. It can be unintentionally introduced into manufacturing through certain chemical reactions.

The FDA is testing all ARBs for these impurities. It had to design a special test after it learned that some ingredients imported from one company in China, Zhejiang Huahai Pharmaceuticals, were tainted.

The FDA placed Zhejiang Huahai Pharmaceuticals on an import alert at the end of September, meaning all active pharmaceutical products and finished products made by the company will not be permitted to enter the United States. The FDA made that decision after its recent inspection of the facility.

Aurobindo, which makes the ingredient for ScieGen's irbesartan products, is recalling all unexpired lots of its irbesartan API supplied to the US market with NDEA. FDA and Aurobindo laboratory testing confirmed NDEA in certain lots of their irbesartan API.

Not all medicine containing valsartan or irbesartan is recalled. This recall affects about 1% of the irbesartan drug products in the US market, according to the FDA.

Talk with your doctor or pharmacist before changing any medicine. Because not all valsartan and irbesartan drugs are involved in the recall, you might be able to switch to a version by another company. The FDA keeps a second list of valsartan products that are not recalled.

If your drug is on the recall list, the FDA suggests taking it until your doctor or pharmacist provides a replacement.

It's unclear exactly what the cancer risk is if you take the contaminated valsartan or irbesartan pills; the FDA believed that the risk was low with the valsartan recall. It estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) containing NDMA from these recalled batches daily for four years, there may be one additional case of cancer over the lifetimes of 8,000 people. Many patients take a much lower dose of valsartan, and therefore their risks are theoretically much lower.

The FDA said it will continue to test all products containing valsartan and similar drugs for the presence of impurities.

California Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 310885

Reported Deaths: 6955
CountyConfirmedDeaths
Los Angeles1274393744
Riverside24765537
Orange22650412
San Diego18863420
San Bernardino18275304
Imperial7759132
Fresno762787
Alameda7485147
San Joaquin627968
Kern619597
Santa Clara5863166
Tulare5678152
Sacramento515279
Contra Costa446088
Stanislaus436450
San Francisco431650
Ventura409353
Santa Barbara386829
San Mateo3846112
Marin336430
Kings285539
Monterey241918
Solano207528
Merced179312
Sonoma156114
Placer102111
San Luis Obispo9054
Madera8578
Yolo83928
Santa Cruz5373
Napa4774
Butte3384
Sutter3374
San Benito3112
El Dorado3070
Lassen2610
Shasta1766
Humboldt1654
Glenn1640
Nevada1631
Yuba1633
Lake1081
Mendocino1070
Colusa1030
Tehama981
Calaveras670
Tuolumne640
Del Norte600
Mono491
Siskiyou410
Amador360
Inyo341
Mariposa311
Plumas170
Alpine20
Trinity20
Sierra10
Unassigned00
Chico
Clear
84° wxIcon
Hi: 103° Lo: 67°
Feels Like: 84°
Oroville
Clear
85° wxIcon
Hi: 104° Lo: 68°
Feels Like: 85°
Paradise
Clear
84° wxIcon
Hi: 96° Lo: 68°
Feels Like: 84°
Chester
Clear
59° wxIcon
Hi: 84° Lo: 53°
Feels Like: 59°
Red Bluff
Clear
84° wxIcon
Hi: 104° Lo: 67°
Feels Like: 84°
Willows
Clear
84° wxIcon
Hi: 106° Lo: 63°
Feels Like: 84°
There is a Red Flag Warning in Modoc county today and tomorrow with temperatures getting as hot as 110 degrees for some in the Valley by Wednesday.
KHSL Severe
KHSL Radar
KHSL Temperatures

Community Events